CASP3 and neoplasm: To further conform the pro-apoptotic activity of α1(IV)NC1 also partly regulated by caspase-3 activation and apoptosis, we carried in-vitro tumor studies with α1(IV)NC1, or α1(IV)NC1 co-administrated with caspase-3 inhibitor DEVD to tumor bearing mice.